research.sunnybrook.ca

Sunnybrook Clinical Trials

Clinical trials drive breakthroughs in care and are a key component of Sunnybrook’s vision to invent the future of health ...
research.sunnybrook.ca

A new era in women’s brain research

October 7, 2026 – Women are disproportionately affected by Alzheimer’s disease, and growing evidence suggests that menopause is not only a reproductive transition, but an important transition for the ...
research.sunnybrook.ca

A breakthrough in menopause research: Scientists uncover biological links between menopause and brain aging

Toronto, ON (October 1, 2026) – New Sunnybrook-led research provides evidence for the first time that menopause-related biological changes that involve the brain are detectable in blood and ...
research.sunnybrook.ca

Dr. Gideon Cohen re-appointed Bernard S. Goldman Chair in Cardiovascular Surgery

Sunnybrook Health Sciences Centre is pleased to announce the re-appointment of Dr. Gideon Cohen as the Bernard S. Goldman Chair in Cardiovascular Surgery for a five-year term. The endowed academic ...
research.sunnybrook.ca

Dr. Jennifer Rabin appointed to the Sunnybrook Professorship in Neurology

Sunnybrook Health Sciences Centre is pleased to announce the appointment of Dr. Jennifer Rabin to the Sunnybrook Professorship in Neurology, jointly shared by Sunnybrook and the University of ...
research.sunnybrook.ca

Sunnybrook study highlights barriers to health care access for Deaf Ontarians

During a hospital visit for severe back pain, Mihret Tekle was prescribed the wrong medication after communication broke down in the absence of an interpreter. For Mihret, a member of Ontario’s Deaf ...
research.sunnybrook.ca

On-site rapid testing leads to decrease in emergency department visits among long term care residents

A study led by Sunnybrook Health Sciences Centre, Michael Garron Hospital, and Humber River Health, in partnership with 20 long-term care (LTC) homes across Toronto, has found that on-site rapid ...
research.sunnybrook.ca

World first: focused ultrasound opens blood-brain barrier for delivery of therapeutic in Parkinson’s disease

In a groundbreaking, world-first clinical trial, a team of researchers from Sunnybrook Health Sciences Centre and University Health Network are using focused ultrasound technology to deliver a ...
research.sunnybrook.ca

World first: Canadian innovation enhances drug access to brain areas affected by ALS

The research team comprised of neurosurgeons, physicists from the focused ultrasound lab, ALS clinician-researchers, imaging research technicians, and anesthesiologist. Toronto, ON (May 9, 2025) – ...
research.sunnybrook.ca

Sunnybrook researchers awarded over $7M in CIHR funding

Sunnybrook scientists are inventing the future of health care by tackling health care’s most challenging problems. The Canadian Institutes of Health Research (CIHR) recently awarded Sunnybrook ...
research.sunnybrook.ca

Levetiracetam for Persons at Risk for Alzheimer’s Disease (ALEVIATE-2)

A Proof-of-Concept, Multicentre, Phase IIb, Randomized Double-Blind Crossover Trial of Levetiracetam vs Placebo for Hippocampal Hyperactivity in Cognitively Normal Individuals at Risk for Alzheimer's ...
research.sunnybrook.ca

Two Sunnybrook scientists awarded Canada Research Chairs

Two scientists from Sunnybrook Research Institute (SRI) have been awarded a Canada Research Chair (CRC), the country’s highest research honour. Dr. Julie Hallet, Associate Scientist in the Evaluative ...